Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Rebecca L Krain"'
Autor:
Rebecca L. Krain, Carolyn J. Kushner, Meera Tarazi, Rebecca G. Gaffney, Andrea C. Yeguez, Danielle E. Zamalin, David R. Pearson, Rui Feng, Aimee S. Payne, Victoria P. Werth
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Pemphigus, an autoimmune blistering disease that affects the skin and mucous membranes, adversely impacts patients' quality of life (QOL). While there are various QOL measurement tools that can be used in this disease, few studies have assessed how a
Externí odkaz:
https://doaj.org/article/ed7544ca6db24a58b145e4187746d39b
Publikováno v:
F1000Research, Vol 8 (2019)
Cutaneous lupus erythematosus (CLE) is an autoimmune disease that can be associated with systemic lupus erythematosus (SLE) symptoms. The pathogenesis of both CLE and SLE is multifactorial, involving genetic susceptibility, environmental factors, and
Externí odkaz:
https://doaj.org/article/0d5ec02b28ea4c5fa93076e2ae647b44
Autor:
Rui Feng, Srita Chakka, Victoria P. Werth, Joan T. Merrill, Josef Symon S. Concha, Rebecca L Krain, Sarah A. Ahmed
Publikováno v:
J Am Acad Dermatol
Background Outcome measures of clinical trials in cutaneous lupus erythematosus (CLE) should reflect clinically meaningful improvement in disease activity, as measured by the Cutaneous Lupus Disease Area and Severity Index activity score (CLASI-A). O
Autor:
Josef Symon S. Concha, Victoria P. Werth, Rebecca L Krain, D. Yan, Danielle Zamalin, Rui Feng, Sarah A. Ahmed, Joyce Okawa, Srita Chakka
Publikováno v:
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
Lupus Science & Medicine
Lupus Science & Medicine
ObjectiveThere is a need to identify concerns unique to patients with cutaneous lupus erythematosus (CLE), which may not be captured by current common-practice dermatological quality-of-life tools. This study formally characterises what bothers patie
Autor:
Rebecca G. Gaffney, Christina E. Bax, Emily Keyes, Victoria P. Werth, Robert Borucki, Steffan W. Schulz, Rui Feng, Josef Symon S. Concha, Joyce Okawa, D. Yan, Adarsh Ravishankar, Rebecca L Krain, Lisa Pappas-Taffer
Publikováno v:
Journal of the American Academy of Dermatology. 86:948-949
Publikováno v:
Ann Transl Med
Cutaneous lupus erythematosus (CLE) has a profound impact on a patient’s quality of life (QoL), despite epidemiologic differences disease presentation. Disease activity, rather than damage, has a greater impact on QoL, and improvement in disease ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cc06516e208e26381632f7238cde173
https://europepmc.org/articles/PMC8033394/
https://europepmc.org/articles/PMC8033394/
Autor:
Josef Symon S. Concha, Joseph F. Merola, Victoria P. Werth, Rebecca L Krain, Srita Chakka, Benjamin F. Chong
Publikováno v:
Ann Transl Med
Cutaneous lupus erythematosus (CLE) can present with or without features of systemic lupus erythematosus (SLE), with estimates of the incidence of isolated skin disease almost equaling the incidence of those with systemic disease. However, despite th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e5860ae87598d4b81a1695536c28f76
https://europepmc.org/articles/PMC8033342/
https://europepmc.org/articles/PMC8033342/
Autor:
Rebecca L Krain, Samir Ben Ahmed, Christina E. Bax, Victoria P. Werth, Aimee S. Payne, Rui Feng, Srita Chakka
Publikováno v:
Br J Dermatol
Autor:
Rebecca L Krain, Sarah A. Ahmed, Josef Symon S. Concha, Galen Foulke, Victoria P. Werth, Danielle Zamalin, Srita Chakka
Publikováno v:
Journal of the American Academy of Dermatology. 86(3)
Background Existing criteria to improve the probability of capturing dermatomyositis (DM) include muscle biopsy but little is known about whether less invasive diagnostic procedures may be just as useful. Objective We aimed to determine whether skin
Publikováno v:
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 154(5)
The management of autoimmune blistering diseases (AIBD) is therapeutically challenging, particularly in patients who plan to conceive, or are pregnant or breastfeeding. Not only is a patient's immune system altered by pregnancy-associated hormonal ch